What is the benefit of asprin in reducing colorectal cancer recurrence? Elizabeth Tracey reports
All Podcasts – Johns Hopkins Medicine Podcasts
October 20, 20251m 5s
Audio is streamed directly from the publisher (media.blubrry.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
People who’ve had colorectal cancer and who have a mutation known as PI3 kinase benefit from taking asprin to prevent recurrence, a new study shows. William Nelson, director of the Kimmel Cancer Center at Johns Hopkins, describes the findings. Nelson: There were …